21 Results for "

nuclear receptor modulator

" in MedChemExpress (MCE) Product Catalog:
Products (21)

21 Results for "nuclear receptor modulator" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-14383
CAS No.: 1182367-47-0
Purity:  99.80%
Synonyms: RAD140; EP0062
Vosilasarm (RAD140) is a potent, orally active, nonsteroidal selective androgen receptor modulator (SARM) with a Ki of 7 nM. Vosilasarm shows good selectivity over other steroid hormone nuclear receptors .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-111498A
CAS No.: 610318-54-2
Purity:  99.76%
Synonyms: Abequolixron
Target:  

LXR

Research Areas:  

Inflammation/Immunology Cancer

RGX-104 is an orally bioavailable and potent liver-X nuclear hormone receptor (LXR) agonist that modulates innate immunity via transcriptional activation of the ApoE gene.
loading...
    loading...
Cat. No.: HY-15731
CAS No.: 15183-37-6
Purity:  99.76%
Estetrol, an orally active estrogen synthesized exclusively during pregnancy by the human fetal liver, is a selective nuclear estrogen receptor modulator. Estetrol binds ERα as well as ERβ (with a fourfold lower affinity). Estetrol increases eNOS expression/activity and NO synthesis in endothelial cells. Estetrol exerts estrogenic actions on the endometrium or the central nervous system but presents antagonistic effects on the breast. Estetrol can be used in contraception and menopausal hormone research .
loading...
    loading...
Cat. No.: HY-P1732
CAS No.: 203716-10-3
Research Areas:  

Cancer

Transportan is an amphipathic cell-penetrating peptide containing 12 functional amino acids from the amino terminus of the neuropeptide galanin and mastoparan in the carboxyl terminus, connected via a lysine. Transportan interacts with galanin receptors and G-proteins, modulates GTPase activity, enters cells via direct translocation and endocytic pathways, accumulates in cytoplasmic, nuclear, and membranous structures, and delivers cargo including peptides, PNAs, proteins, siRNA, and liposomes [12].
loading...
    loading...
Cat. No.: HY-135572
CAS No.: 958323-31-4
Purity:  99.92%
Research Areas:  

Neurological Disease Cancer

TLX agonist 1 (ccrp2) is an orphan nuclear receptor tailless (TLX, NR2E1) modulator (EC50=1μM; Kd= 650 nM). TLX agonist 1 potentiates TLX transcriptional repressive activity .
loading...
    loading...
Cat. No.: HY-N3741
CAS No.: 18296-45-2
Synonyms: Didrovaltratum
Didrovaltrate (Didrovaltratum) is an L-type calcium channel blocker, ROS scavenger, autophagy enhancer, and lipid accumulation inhibitor. Didrovaltrate blocks L-type calcium currents in a concentration-dependent manner, shifts the current-voltage curve upward, modulates steady-state inactivation kinetics, and inhibits the nuclear translocation of glucocorticoid receptors. Didrovaltrate reduces ROS levels, downregulates the expression of muscle atrophy-related genes, enhances autophagy via lipophagy, and decreases Oleic acid-induced lipid accumulation. Didrovaltrate exhibits cytotoxic activity against cancer cells. Didrovaltrate can be used in research related to skeletal muscle atrophy, non-alcoholic fatty liver disease, breast cancer, lung cancer, gastric cancer, and prostate cancer .
loading...
    loading...
Cat. No.: HY-U00429
CAS No.: 1015231-98-7
Research Areas:  

Neurological Disease

NOT Receptor Modulator 1 is a nuclear receptor Nurr-1/NOT modulator extracted from patent WO 2008034974 A1, Example 39 in table1.
loading...
    loading...
Cat. No.: HY-W649594
CAS No.: 22978-55-8
Research Areas:  

Inflammation/Immunology Cancer

NR2F6 modulator-2 (Compound I) is an autorepressed orphan nuclear receptor NR2F6 (Nuclear Receptor subfamily 2 group F member 6) modulator. NR2F6 modulator-2 can inhibits the recruitment of the bio-NSD1 peptide with an IC50 of 2.0 equivalents of NR2F6. NR2F6 modulator-2 can be used for the researches of cancer and immunology .
loading...
    loading...
Cat. No.: HY-103578
CAS No.: 404920-28-1
Target:  

Androgen Receptor

Research Areas:  

Metabolic Disease

S-40503 is a tissue-selective androgen receptor (AR) agonist with a Ki of 14.9 nM for rat AR. S-40503 binds to AR with high specificity, exerts full agonistic effects in bone and muscle, acts as a partial agonist in the prostate, and preferentially targets anabolic tissues rather than androgen-dependent tissues. S-40503 can be used in the research of osteoporosis .
loading...
    loading...
Cat. No.: HY-164506
CAS No.: 2375659-15-5
Target:  

FAAH

Research Areas:  

Neurological Disease Cancer

NRMA-8 is a brain-penetrant small molecule nuclear receptor modulator. NRMA-8 is promising for research of central nervous system disorders, including Alzheimer's disease, Parkinson's disease, demylenation disorders and glioblastomas .
loading...
    loading...
Cat. No.: HY-118912
CAS No.: 457937-39-2
BMH-9 (Compound Z54) is a modulator for nuclear receptor subfamily 2, group F, member 6 (NR2F6) (also known as nuclear orphan receptor Ear2) . BMH-9 is an activator for p53 signaling pathway through interaction with DNA. BMH-9 inhibits proliferation of human cancer cells, exhibits antitumor efficacy in NOD-SCID mouse models .
loading...
    loading...
Cat. No.: HY-164508
CAS No.: 2375659-13-3
Target:  

Drug Intermediate

Research Areas:  

Neurological Disease

NRMA-6, an amide prodrug, is a nuclear receptor modulator .
loading...
    loading...
Cat. No.: HY-15731S
Purity:  97.50%
Estetrol-d4 is the deuterium labeled Estetrol. Estetrol, a natural estrogen synthesized exclusively during pregnancy by the human fetal liver, is a selective nuclear estrogen receptor modulator. Estetrol exerts estrogenic actions on the endometrium or the central nervous system but presents antagonistic effects on the breast .
loading...
    loading...
Cat. No.: HY-15731S1
CAS No.: 2734920-42-2
Estetrol-d4 (Major) is the deuterium labeled Estetrol (HY-15731). Estetrol, an orally active estrogen synthesized exclusively during pregnancy by the human fetal liver, is a selective nuclear estrogen receptor modulator. Estetrol binds ERα as well as ERβ (with a fourfold lower affinity). Estetrol increases eNOS expression/activity and NO synthesis in endothelial cells. Estetrol exerts estrogenic actions on the endometrium or the central nervous system but presents antagonistic effects on the breast. Estetrol can be used in contraception and menopausal hormone research .
loading...
    loading...
Cat. No.: HY-164504
CAS No.: 2375659-17-7
Target:  

MMP

Research Areas:  

Neurological Disease

NRMA-10, an amide prodrug, is a brain-penetrant nuclear receptor modulator. NRMA-10 increases brain expression of Adam10. NRMA-10 preferres distribution to the CNS compared to the periphery. NRMA-10 can be used for the study of central nervous system (CNS) disorders .
loading...
    loading...
Cat. No.: HY-164512
CAS No.: 1417653-47-4
Target:  

Drug Intermediate

Research Areas:  

Neurological Disease

NRMA-I is the amide produrg of the small molecule nuclear receptor modulator. NRMA-I exhibits a higher exposure in the brain, indicating that a good blood-brain barrier (BBB) penetration. NRMA-I can be used for research of central nervous system diseases related to nuclear receptors, such as Alzheimer's disease and Parkinson's disease .
loading...
    loading...
Cat. No.: HY-164507
CAS No.: 2375659-14-4
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

NRMA-7 is a BBB-penetrable small molecule nuclear receptor modulator. NRMA-7 can be used in the study of central nervous system diseases .
loading...
    loading...
Cat. No.: HY-164505
CAS No.: 2375659-16-6
Target:  

Drug Intermediate

Research Areas:  

Neurological Disease

NRMA-9 is the amide produrg of the small molecule nuclear receptor modulator. NRMA-9 exhibits a higher exposure in the brain, indicating that a good blood-brain barrier (BBB) penetration. NRMA-9 can be used for research of central nervous system diseases related to nuclear receptors, such as Alzheimer's disease and Parkinson's disease .
loading...
    loading...
Cat. No.: HY-111498AR
CAS No.: 610318-54-2
Synonyms: Abequolixron (Standard)
Target:  

Reference Standards LXR

Research Areas:  

Inflammation/Immunology Cancer

RGX-104 (Standard) is the analytical standard of RGX-104 (HY-111498A). This product is intended for research and analytical applications. RGX-104 is an orally bioavailable and potent liver-X nuclear hormone receptor (LXR) agonist that modulates innate immunity via transcriptional activation of the ApoE gene.
loading...
    loading...
Cat. No.: HY-183309
Target:  

FXR 17β-HSD

Research Areas:  

Inflammation/Immunology

FXR/HSD17B13-modulator-2 is a dual FXR activator and HSD17B13 inhibitor with human FXR EC50 of 128 nM, human HSD17B13 IC50 of 0.18 μM, high selectivity over related nuclear receptors and HSD17B isoforms, and oral effectiveness.FXR/HSD17B13-modulator-2 alleviates fatty liver, regulates lipid metabolism, reduces inflammation, and attenuates hepatic fibrosis.FXR/HSD17B13-modulator-2 is the first non-carboxylic acid dual FXR/HSD17B13 modulator.FXR/HSD17B13-modulator-2 can be used for the research of metabolic dysfunction-associated steatohepatitis .
loading...
    loading...